Principles and mechanisms of peri-implant soft tissue healing

Quintessence International

Volumn 36, Issue 10, 2005, Pages 759-769

  Schultze Mosgau, Stefan ^a   Blatz, Markus B ^b   Wehrhan, Falk ^a   Schlegel, Karl Andreas ^c   Thorwart, Michael ^a   Holst, Stefan ^c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Fibrosis; Implants; Soft tissue; Transforming growth factor beta; Wound healing

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE REGENERATION; DRUG ANTAGONISM; FIBROSIS; HUMAN; PATHOPHYSIOLOGY; PERIODONTIUM; PHYSIOLOGY; SCAR; TOOTH IMPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

CICATRIX; DENTAL IMPLANTS; FIBROSIS; HUMANS; OSSEOINTEGRATION; PERIODONTIUM; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME; WOUND HEALING;

EID: 26844569876     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Hurzeler MB, Weng D. Periimplant tissue management: optimal timing for an aesthetic result. Pract Periodontics Aesthet Dent 1996;8:857-869.
2. Weber HP, Cochran DL. The soft tissue response to osseointegrated dental implants. J Prosthet Dent 1998;79:79-89.
3. Albrektsson T, Branemark PI, Hansson HA, Lindstrom J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-170.
4. Lazzara RJ. Managing the soft tissue margin: The key to implant aesthetics. Pract Periodontics Aesthet Dent 1993;5:81-88.
5. Yu W, Naim JO, Lanzafame RJ. Effects of photostimulation on wound healing in diabetic mice. Lasers Surg Med 1997; 20: 56-63.
6. Cranin AN. Implant surgery: The management of soft tissues. J Oral Implantol 2002;28:230-237.
7. Heller AL, Heller RL, Cook G, D'Orazio R, Rutkowski J. Soft tissue management techniques for implant dentistry: A clinical guide. J Oral Implantol 2000;26: 91-103.
8. Gailit J, Clark RA. Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994;6: 717-725.
9. Samuels P, Tan AK. Fetal scarless wound healing. J Otolaryngol 1999;28:296-302.
10. Witte MB, Barbul A. General principles of wound healing. Surg Clin North Am 1997;77:509-528.
11. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. Studies on cytokines related to wound healing in donor site wound fluid. J Dermatol Sci 1995;10: 241-245.
12. Vegesna V, McBride WH, Taylor JM, Withers HR. The effect of interleukin-1 beta or transforming growth factor-beta on radiation-impaired murine skin wound healing. J Surg Res 1995;59:699-704.
13. Vogt PM, Lehnhardt M, Wagner D, Jansen V, Krieg M, Steinau HU. Determination of endogenous growth factors in human wound fluid: Temporal presence and profiles of secretion. Plast Reconstr Surg 1998;102:117-123.
14. Ruoslahti E, Noble NA, Kagami S, Border WA. Integrins. Kidney Int Suppl 1994;44:17-22.
15. Slavin J. The role of cytokines in wound healing. J Pathol 1996;178:5-10.
16. Mann A, Breuhahn K, Schirmacher P, Blessing M. Keratinocyte-derived granulocyte-macrophage colony stimulating factor accelerates wound healing: Stimulation of keratinocyte proliferation, granulation tissue formation, and vascularization. J Invest Dermatol 2001;117:1382-1390.
17. Matsumoto K, Robb E, Warden G, Nordlund J. The expression of cytokines, growth factors and ICAM-1 in the healing of human cutaneous xenografts on nude mice. Exp Dermatol 1997;6:13-21.
18. Goretsky MJ, Harriger MD, Supp AP, Greenhalgh DG, Boyce ST. Expression of interleukin-1alpha, interleukin-6, and basic fibroblast growth factor by cultured skin substitutes before and after grafting to full-thickness wounds in athymic mice. J Trauma 1996;40:894-899.
19. Grayson LS, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. Quantitation of cytokine levels in skin graft donor site wound fluid. Burns 1993;19:401-405.
20. Kaiura TL, Itoh H, Kubaska SM III, McCaffrey TA, Liu B, Kent KC. The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg 2000;31:577-584.
21. Karl P, Heiner H, Tilgner-Peter A. Free skin-adipose tissue flap transplantation in rats. Z Exp Chir 1978;11:251-257.
22. Schultze-Mosgau S, Rodel F, Keilholz L, et al. Vascularization of free myocutaneous gracilis flaps in replacement transplantation after preoperative radiotherapy. An experimental study. Strahlenther Onkol 2000;176:498-505.
23. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-652.
24. Schierano G, Bellone G, Cassarino E, Pagano M, Preti G, Emanuelli G:. Transforming growth factor-beta and interleukin 10 in oral implant sites in humans. J Dent Res 2003;82:428-432.
25. Cornelini R, Rubini C, Fioroni M, Favero GA, Strocchi R, Piattelli A. Transforming growth factor-beta 1 expression in the peri-implant soft tissues of healthy and failing dental implants. J Periodontol 2003;74:446-450.
26. Fray TR, Wood EJ. Effect of growth factors on fibro blast migration in a simplified wound healing model. Biochem Soc Trans 1996;24:258-265.
27. Ihn H, Kikuchi K, Soma Y, et al. The stimulatory effects of PDGF and TGF-beta 1 on dermal fibroblast attachment. Acta Derm Venereol 1995;75:367-371.
28. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987;84:5788-5792.
29. Gailit J, Welch MP, Clark RA. TGF-beta 1 stimulates expression of keratinocyte integrins during reepithelialization of cutaneous wounds. J Invest Dermatol 1994;103:221-227.
30. Kishi K, Nakajima H, Tajima S. Differential responses of collagen and glycosaminoglycan syntheses and cell proliferation to exogenous transforming growth factor beta 1 in the developing mouse skin fibroblasts in culture. Br J Plast Surg 1999;52:579-582.
31. Reed MJ, Vernon RB, Abrass IB, Sage EH. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 1994;158:169-179.
32. Wang JF, Olson ME, Reno CR, Kulyk W, Wright JB, Hart DA. Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res 2000;41:195-211.
33. Pablos JL, Everett ET, Harley R, Le Roy EC, Norris JS. Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse. Lab Invest 1995;72:670-678.
34. Frank R, Adelmann-Grill BC, Herrmann K, Haustein UF, Petri JB, Heckmann M: Transforming growth factor-beta controls cell-matrix interaction of microvascular dermal endothelial cells by downregulation of integrin expression. J Invest Dermatol 1996;106:36-41.
35. Heino J, Ignotz RA, Hemler ME, Crouse C, Massague J. Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit. J Biol Chem 1989;264:380-388.
36. Kagami S, Border WA, Ruoslahti E, Noble NA. Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest 1993;69:68-76.
37. Lorenz HP, Adzick NS. Scarless skin wound repair in the fetus. West J Med 1993;159:350-355.
38. Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC: Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing. J Cell Physiol 1991;148:157-173.
39. Fajardo LF, Prionas SD, Kwan HH, Kowalski J, Allison AC. Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996;74:600-608.
40. Yang EY, Moses HL. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990;111:731-741.
41. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA. Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996;97:1436-1446.
42. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83:4167-4171.
43. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-791.
44. Roberts AB, Kim SJ, Noma T, et al. Multiple forms of TGF-beta: Distinct promoters and differential expression. Ciba Found Symp 1991;157:7-15.
45. Khalil N. TGF-beta: From latent to active. Microbes Infect 1999;1:1255-1263.
46. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.
47. Olofsson A, Ichijo H, Moren A, ten Dijke P, Miyazono K, Heldin CH. Efficient association of an amino-terminally extended form of human latent transforming growth factor-beta binding protein with the extracellular matrix. J Biol Chem 1995;29;270:31294-31297.
48. Saharinen J, Hyytiainen M, Taipale J, Keski-Oja J. Latent transforming growth factor-beta binding proteins (LTBPs) - Structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 1999;10:99-117.
49. Barcellos-Hoff MH. Latency and activation in the control of TGF-beta. J Mammary Gland Biol Neoplasia 1996;1:353-363.
50. Flaumenhaft R, Abe M, Mignatti P, Rifkin DB. Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: Regulation of plasminogen activator activity. J Cell Biol 1992;118:901-909.
51. Yehualaeshet T, O'Connor R, Green-Johnson J, et al. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 1999;155:841-851.
52. Gleizes PE, Munger JS, Nunes I, et al. TGF-beta latency: Biological significance and mechanisms of activation. Stem Cells 1997;15:190-197.
53. Gleizes PE, Rifkin DB. Activation of latent TGF-beta. A required mechanism for vascular integrity. Pathol Biol (Paris) 1999;47:322-329.
54. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB. Latent transforming growth factor-beta: Structural features and mechanisms of activation. Kidney Int 1997;51:1376-1382.
55. Brown PD, Wakefield LM, Levinson AD, Sporn MB. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 1990;3:35-43.
56. Cheifetz S, Like B, Massague J. Cellular distribution of type I and type II receptors for transforming growth factor-beta. J Biol Chem 1986;261:9972-9978.
57. Cheifetz S, Andres JL, Massague J. The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor. J Biol Chem 1988;263:16984-16991.
58. Cheifetz S, Massague J. Transforming growth factor-beta (TGF-beta) receptor proteoglycan. Cell surface expression and ligand binding in the absence of glycosaminoglycan chains. J Biol Chem 1989;264:12025-12028.
59. Derynck R, Feng XH. TGF-beta receptor signaling. Biochim Biophys Acta 1997;24;1333:105-150.
60. Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell 1991; 67:785-795.
61. Lopez-Casillas F, Payne HM, Andres JL, Massague J, Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J Cell Biol 1994;124:557-568.
62. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF beta signaling receptor. Cell 1993;73:1435-1444.
63. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: A new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 2000;11:1023-1035.
64. Lawler S, Candia AF, Ebner R, et al. The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta 1. Development 1994;120:165-175.
65. Rodriguez C, Chen F, Weinberg RA, Lodish HF. Cooperative binding of transforming growth factor (TGF)-beta 2 to the types I and II TGF-beta receptors. J Biol Chem 1995;270:15919-15922.
66. Wrana JL, Attisano L, Carcamo J, et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-1014.
67. Zhang Y, Derynck R. Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 1999;9:274-279.
68. Wu RY, Zhang Y, Feng XH, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol 1997;17:2521-2528.
69. Miyazono K, ten Dijke P, Heldin CH. TGF-beta signaling by Smad proteins. Adv Immunol 2000;75:115-157.
70. Liu F, Pouponnot C, Massague J. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev 1997;11:3157-3167.
71. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331: 1286-1292.
72. Eckes B, Zigrino P, Kessler D, et al. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000;19:325-332.
73. Broekelmann TJ, Limper AH, Colby TV, McDonald JA. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci U S A 1991;88:6642-6646.
74. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991;324:933-940.
75. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999;43:179-184.
76. Querfeld C, Eckes B, Huerkamp C, Krieg T, Sollberg S. Expression of TGF-beta 1, -beta 2 and -beta 3 in localized and systemic scleroderma. J Dermatol Sci 1999;21:13-22.
77. Schmid P, Itin P, Cherry G, Bi C, Cox DA. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 1998;152:485-493.
78. Gentilhomme E, Neveux Y, Lebeau J, et al. Modulation of a fibrotic process induced by transforming growth factor beta-1 in dermal equivalents. Cell Biol Toxicol 1999;15:229-238.
79. Shinozaki M, Kawara S, Hayashi N, Kakinuma T, Igarashi A, Takehara K. Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor beta-simultaneous application with basic fibroblast growth factor causes persistent fibrosis. Biochem Biophys Res Commun 1997;18;237:292-296.
80. Adzick NS, Lorenz HP. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994;220:10-18.
81. Gabka CJ, Benhaim P, Mathes SJ, et al. An experimental model to determine the effect of irradiated tissue on neutrophil function. Plast Reconstr Surg 1995;96:1676-1688.
82. Bernstein EF, Salomon GD, Harisiadis L, et al. Collagen gene expression and wound strength in normal and radiation-impaired wounds. A model of radiation-impaired wound healing. J Dermatol Surg Oncol 1993;19:564-570.
83. Wang Q, Dickson GR, Carr KE. The effect of graft-bed irradiation on the healing of rat skin grafts. J Invest Dermatol 1996;106:1053-1057.
84. Bernstein EF, Harisiadis L, Salomon G, et al. Transforming growth factor-beta improves healing of radiation-impaired wounds. J Invest Dermatol 1991;97:430-434.
85. Schultze-Mosgau S, Wehrhan F, Grabenbauer G, et al. Transforming growth factor beta 1 and beta 2 (TGFbeta(2) / TGFbeta(2)) profile changes in previously irradiated free flap beds. Head Neck 2002;24:33-41.
86. Schultze-Mosgau S, Wehrhan F, Amann K, Radespiel-Troger M, Rodel F, Grabenbauer GG. In vivo TGF-beta 3 expression during wound healing in irradiated tissue. An experimental study. Strahlenther Onkol 2003;179:410-416.
87. Schultze-Mosgau S, Wehrhan F, Rodel F, Amann K, Radespiel-Troger M, Grabenbauer GG. Transforming growth factor-beta receptor-II upregulation during wound healing in previously irradiated graft beds in vivo. Wound Repair Regen 2003;11:297-305.